-
公开(公告)号:US6147050A
公开(公告)日:2000-11-14
申请号:US842234
申请日:1997-04-22
IPC分类号: G01N33/566 , A61K38/00 , A61K48/00 , A61P1/04 , A61P11/00 , A61P27/02 , A61P29/00 , A61P31/04 , A61P43/00 , C07K14/47 , C12N5/00 , C12N5/10 , C12N15/09 , C12N15/12 , C12P21/02 , C12Q1/68 , C12R1/91 , A61K38/16 , C07H21/04 , C07K1/00 , C12P21/06
CPC分类号: C07K14/4705 , A61K38/00 , A61K48/00
摘要: Disclosed is a human FLAP II polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques. Further, antagonists against such polypeptide are disclosed. Such antagonists may be used for therapeutic proposes, for example, for treating inflamation, bronchial asthma and may also be used as gastric cytoprotective agents and to treat human glomerulonephritis. Diagnostic assays for identifying mutations in nucleic acid sequences encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
摘要翻译: 公开了编码这种多肽的人FLAP II多肽和DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法。 此外,公开了抗这种多肽的拮抗剂。 这样的拮抗剂可用于治疗,例如用于治疗炎症,支气管哮喘,也可用作胃细胞保护剂并治疗人肾小球性肾炎。 还公开了用于鉴定编码本发明多肽的核酸序列中的突变并检测本发明多肽的改变水平的诊断测定法。
-
公开(公告)号:US5696076A
公开(公告)日:1997-12-09
申请号:US264003
申请日:1994-06-22
IPC分类号: G01N33/566 , A61K38/00 , A61K48/00 , A61P1/04 , A61P11/00 , A61P27/02 , A61P29/00 , A61P31/04 , A61P43/00 , C07K14/47 , C12N5/00 , C12N5/10 , C12N15/09 , C12N15/12 , C12P21/02 , C12Q1/68 , C12R1/91 , A61K38/16
CPC分类号: C07K14/4705 , A61K38/00 , A61K48/00
摘要: Disclosed is a human FLAP II polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques. Further, antagonist/inhibitors against such polypeptide are disclosed. Such antagonist/inhibitors may be used for therapeutic purposes, for example, for treating inflammation, bronchial asthma and may also be used as gastric cytoprotective agents and to treat human glomerulonephritis.
摘要翻译: 公开了编码这种多肽的人FLAP II多肽和DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法。 此外,公开了针对这种多肽的拮抗剂/抑制剂。 这种拮抗剂/抑制剂可用于治疗目的,例如用于治疗炎症,支气管哮喘,也可用作胃细胞保护剂并治疗人类肾小球性肾炎。
-
公开(公告)号:US07803615B1
公开(公告)日:2010-09-28
申请号:US09042583
申请日:1998-03-17
申请人: Jian Ni , Reiner L. Gentz , Guo-Liang Yu , Jeffrey Y. Su , Craig A. Rosen
发明人: Jian Ni , Reiner L. Gentz , Guo-Liang Yu , Jeffrey Y. Su , Craig A. Rosen
IPC分类号: C07K14/705 , C12N5/10 , C12N15/12 , C12N15/62 , C12N15/63
CPC分类号: C07K14/7151 , A61K38/00 , C07K2319/00
摘要: The present invention relates to novel Death Domain Containing Receptor-5 (DR5) proteins which are members of the tumor necrosis factor (TNF) receptor family, and have now been shown to bind TRAIL. In particular, isolated nucleic acid molecules are provided encoding the human DR5 proteins. DR5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying antagonists and antagonists of DR5 activity.
摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族的成员的新的含有死亡域的受体-5(DR5)蛋白,现在已经显示结合TRAIL。 特别地,提供编码人DR5蛋白的分离的核酸分子。 还提供了DR5多肽,载体,宿主细胞以及用于制备它们的重组方法。 本发明还涉及用于鉴定DR5活性的拮抗剂和拮抗剂的筛选方法。
-
公开(公告)号:US07601351B1
公开(公告)日:2009-10-13
申请号:US10602727
申请日:2003-06-25
IPC分类号: A61K39/395 , A61K39/40
CPC分类号: C07K16/00 , C07K2317/56
摘要: The present invention relates to antibodies and related molecules that specifically bind to protective antigen of Bacillus anthracis (PA). Such antibodies have uses, for example, in the prevention and treatment of anthrax and anthrax toxin poisoning. The invention also relates to nucleic acid molecules encoding anti-PA antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same.
摘要翻译: 本发明涉及与炭疽芽孢杆菌(PA)的保护性抗原特异性结合的抗体和相关分子。 这样的抗体具有例如用于预防和治疗炭疽和炭疽毒素中毒的用途。 本发明还涉及编码抗PA抗体的核酸分子,含有这些核酸的载体和宿主细胞及其制备方法。
-
公开(公告)号:US20090208969A1
公开(公告)日:2009-08-20
申请号:US12431986
申请日:2009-04-29
申请人: Jian Ni , Craig A. Rosen , Reiner L. Gentz
发明人: Jian Ni , Craig A. Rosen , Reiner L. Gentz
CPC分类号: C07K14/70535 , A61K38/00 , C07K14/47 , C07K14/705 , C07K14/70503 , C12N9/6421 , C12N9/6475 , C12N9/6489 , C12N9/6491 , C12N2799/026
摘要: Receptor polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing receptor polypeptides and polynucleotides in the design of protocols for the treatment of diseases and diagnostic assays for such conditions.
摘要翻译: 公开了受体多肽和多核苷酸以及通过重组技术产生这种多肽的方法。 还公开了在设计用于治疗疾病的方案和用于这些病症的诊断测定中使用受体多肽和多核苷酸的方法。
-
公开(公告)号:US20090092608A1
公开(公告)日:2009-04-09
申请号:US12241203
申请日:2008-09-30
申请人: Jian Ni , Craig A. Rosen , Reiner L. Gentz
发明人: Jian Ni , Craig A. Rosen , Reiner L. Gentz
IPC分类号: A61K39/395 , C12N15/11 , C07K14/00 , C07K16/18
CPC分类号: C07K16/2878 , C07K2317/73 , C07K2319/30
摘要: The present invention relates to novel members of the Tumor Necrosis Factor family of receptors. The invention provides isolated nucleic acid molecules encoding a human TR2 receptor and two splice variants thereof. TR2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR2 receptor activity. Also provided are diagnostic methods for detecting disease states related to the aberrant expression of TR2 receptors. Further provided are therapeutic methods for treating disease states related to aberrant proliferation and differentiation of cells which express the TR2 receptors.
-
公开(公告)号:US20090062510A1
公开(公告)日:2009-03-05
申请号:US11737622
申请日:2007-04-19
申请人: Jian Ni , Guo-Liang Yu , Pedro Alfonso , Reiner L. Gentz , Jeffrey Y. Su
发明人: Jian Ni , Guo-Liang Yu , Pedro Alfonso , Reiner L. Gentz , Jeffrey Y. Su
IPC分类号: C07K14/52
摘要: Human chemotactic cytokine I polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, auto-immune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptide in a host.
摘要翻译: 公开了人类趋化性细胞因子I多肽和编码这种趋化性细胞因子的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎,自身免疫,慢性和急性炎性和感染性疾病,过敏反应,前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定。
-
公开(公告)号:US20080200391A1
公开(公告)日:2008-08-21
申请号:US12105768
申请日:2008-04-18
申请人: Jian Ni , Ping Feng , Patrick J. Dillon , Reiner L. Gentz , Joseph Merregaert , Patrick Smits
发明人: Jian Ni , Ping Feng , Patrick J. Dillon , Reiner L. Gentz , Joseph Merregaert , Patrick Smits
IPC分类号: A61K38/16 , C07H21/00 , C12N15/63 , C12N5/00 , C12P21/00 , A61P19/00 , C07K16/00 , G01N33/00 , C07K14/00
CPC分类号: C12Q1/6883 , A61K38/00 , A61K48/00 , A61K2039/51 , C07K14/47 , C07K14/51 , C12N2799/026 , C12Q2600/156 , Y10T436/143333
摘要: A human ECM-1 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for stimulating the differentiation in growth of osteoblasts and osteoclasts, which may be used to promote the healing of bone fractures and de novo bone formation, for osteoporosis, for and to promote angiogenesis. Antagonists to the polypeptide of the present invention are also disclosed which may be utilized to treat osteodystrophy, osteohypertrophy, osteoma, osteoblastoma and cancers. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention.
摘要翻译: 公开了编码这种多肽的人ECM-1多肽和DNA(RNA),以及通过重组技术产生此类多肽的方法。 还公开了利用这种多肽刺激成骨细胞和破骨细胞生长分化的方法,其可用于促进骨折愈合和从头骨形成,用于骨质疏松症,促进血管生成。 还公开了本发明多肽的拮抗剂,其可用于治疗骨营养不良,骨质肥大,骨瘤,成骨细胞瘤和癌症。 用于鉴定编码本发明多肽的核酸序列中的突变的诊断测定。
-
9.
公开(公告)号:US07364865B2
公开(公告)日:2008-04-29
申请号:US11381977
申请日:2006-05-05
申请人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
发明人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1(CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子β8(CKbeta8或ckb-8))的分离的核酸分子的治疗组合物和方法。 人单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子β1(CKbeta1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4)以及MPIF-1 ,M-CIF和/或MIP-4多肽本身,以及用于产生它们的载体,宿主细胞和重组方法。
-
公开(公告)号:US07169566B2
公开(公告)日:2007-01-30
申请号:US10979092
申请日:2004-11-02
申请人: Jian Ni , Steven M. Ruben , Laurie A. Brewer , Reiner L. Gentz , Craig A. Rosen
发明人: Jian Ni , Steven M. Ruben , Laurie A. Brewer , Reiner L. Gentz , Craig A. Rosen
CPC分类号: C12N9/6489 , A61K38/00 , C07K14/47 , C07K14/705 , C07K14/70535 , C12N9/00 , C12N9/6475 , C12N9/6491 , C12N2799/026
摘要: The present invention relates to novel metalloproteinase-like proteins. In particular, isolated nucleic acid molecules are provided encoding the human TACE-like and matrilysin-like proteins. TACE-like and matrilysin-like polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TACE-like and matrilysin-like activity. Also provided are diagnostic methods for detecting cancer and therapeutic methods for cancer and other disorders characterized by an over or under production of these metalloproteinases.
摘要翻译: 本发明涉及新型金属蛋白酶样蛋白质。 特别地,提供了分离的核酸分子,其编码人类TACE样和基质溶素样蛋白。 TACE样和基质溶素样多肽也可以作为载体,宿主细胞和用于制备它们的重组方法提供。 本发明进一步涉及用于鉴定TACE样和基质溶素样活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测癌症的诊断方法和癌症的治疗方法以及特征在于这些金属蛋白酶过度或过量生产的其它病症。
-
-
-
-
-
-
-
-
-